IMA Ikena Oncology, Inc. Earnings per share growth this year
ImageneBio Inc develops targeted oncology therapies based on metabolic tumor regulation and patent protection. Analyzing YoY EPS changes helps assess business resilience, with 63.50 representing the current level of this metric. Diversification through biomarkers mitigates scientific risks, while strict FDA oversight and colossal research expenditures block the emergence of low-cost generics.
Financial and market metric breakdowns for ikenaoncology.com (IMA)
- market value and analyst target forecast:
- market capitalization data:
- book capitalization information:
- debt burden and liquidity indicators:
- company profitability and valuation multiples indicators:
IMA - Net Profit|Expected Net Profit ImageneBio Inc|IMA - P/E Multiple|Future Price to Earnings Ikena Oncology|IMA - PEG Multiple|Total Company Value to Operating Income Before Depreciation Ratio IMA|IMA - Profit before payment of interest, taxes and amortization|Net earnings per one share for the last twelve months Ikena Oncology|IMA - Net earnings per share for the last 12 months|Year-over-year earnings per one share growth for the last 12 months ikenaoncology.com|IMA - Earnings growth in current year|Consensus forecast of earnings per share growth for next year ImageneBio Inc
Fundamental valuation:IMA (Ikena Oncology, Inc.)
The biotechnology sector is extremely sensitive to the cost of borrowed capital and external macroeconomic shocks. Patent protection for cancer inhibitors and stringent FDA oversight create a significant barrier to entry for competitors of ImageneBio Inc (IMA). This indicator measures the rate of change in earnings per share relative to the previous year. By analyzing the year-over-year EPS comparison, an investor can discern the actual efficiency of the business's adaptation to current rates. The trend of this metric serves as a signal of the company's financial stability.
Direct competitors
argenx N.V. (ARGX) - Earnings growth in current year|Earnings per share growth in current year BioNTech Group|Earnings per share growth this year ABVX (abivax.com)|Earnings growth in current year ADMA|PTGX - Earnings per share growth rate in current year|Earnings growth in current year IMVT (Immunovant)|Expected net earnings per share growth this year Kiniksa Pharmaceuticals, Ltd. (KNSA)|GRFS - Earnings per share growth in current year|Adaptive Biotechnologies Inc. (ADPT) - Net earnings per share growth this year|CLDX: Earnings growth in current year|auriniapharma.com (AUPH) - Earnings growth in current year|BCRX (BioCryst Pharmaceuticals) - Earnings growth in current year|VERA - Net earnings per share change in current year|Earnings growth in current year DNTH|PHVS - Earnings per share growth rate in current year|Earnings per share growth in current year AbCellera Biologics ABCL|TRML: Earnings per share growth this year|Precigen - Earnings growth in current year|Earnings per share growth rate in current year Pharming Group NV|NKTR: Earnings growth in current year|UPB (Upstream Pharma) - Earnings per share growth in current year|ZBIO (Zenas Biopharma Inc) - Earnings growth in current year|immunome.com (IMNM) - Expected net earnings per share growth this year|Earnings per share growth in current year Gossamer Bio (GOSS)|KALV - Earnings per share growth rate in current year|Septerna Corp - Net earnings per share growth this year|Earnings per share increase in current year PVLA|Savara Inc. - Earnings growth in current year|Expected net earnings per share growth this year rigel.com RIGL|AnaptysBio (ANAB) - Earnings per share growth in current year|Earnings per share growth this year ATXS|ENGN (enGene Bio) - Earnings growth in current year|Net earnings per share growth this year RAPT Therapeutics Inc. (RAPT)|Earnings growth in current year JBIO|Expected net earnings per share growth this year aclaristx.com|Earnings per share growth in current year Kyverna Therapeutics, Inc. KYTX|TLSA - Net earnings per share growth this year|Cabaletta Bio, Inc - Earnings growth in current year|VTYX - Earnings growth in current year|Theratechnologies Inc. (THTX) - Earnings per share growth in current year|Earnings per share trend in current year AVTX (avalotx.com)|ELDN (Eledon Pharmaceuticals, Inc.) - Earnings growth in current year|AGEN: Earnings per share increase in current year|Earnings growth in current year CLYM|Earnings growth in current year Zura Bio Ltd (ZURA)|Earnings per share growth in current year aTyr Pharma, Inc. ATYR|Earnings per share increase in current year ADAG|STTK - Earnings per share growth in current year|Equillium, Inc. (EQ) - Net earnings per share growth this year|CNTB: Earnings growth in current year|Immunic (IMUX) - Earnings growth in current year|Net earnings per share growth this year ATRA|IFRX: Earnings per share increase in current year|Earnings growth in current year XFOR|Expected net earnings per share growth this year adicetbio.com|Earnings per share growth in current year Celularity CELU|INMB - Net earnings per share growth this year|BRNS - Earnings per share growth in current year|kezarlifesciences.com (KZR) - Net earnings per share growth this year|SABS (SAB Biotherapeutics, Inc.) - Net earnings per share growth this year|Akari Therapeutics PLC (AKTX) - Earnings growth in current year|Earnings per share growth in current year Enlivex Therapeutics Ltd|Earnings per share growth this year QTTB (Q32 Bio Corp)|Earnings growth in current year GOVX|EDSA - Earnings per share growth rate in current year|Earnings growth in current year IBIO (iBio)|Expected net earnings per share growth this year Carisma Therapeutics Inc (CARM)|XTLB - Earnings per share growth in current year|Bolt Biotherapeutics (BOLT) - Net earnings per share growth this year|HCWB: Earnings growth in current year|Aptevo Therapeutics Inc. (APVO) - Earnings growth in current year|AIM (AIM ImmunoTech Inc.) - Earnings growth in current year|ADTX - Net earnings per share change in current year|Earnings growth in current year GRI|XRTX - Earnings per share growth rate in current year|Earnings per share growth in current year Vyome Holdings Inc HIND|REVB: Earnings per share growth this year|Indaptus Therapeutics, Inc. - Earnings growth in current year|Earnings per share growth rate in current year Scinai Immunotherapeutics Ltd|CALI: Earnings growth in current year|AFMD (Affimed N.V.) - Earnings per share growth in current year|ALLK (Allakos Inc) - Earnings growth in current year|HOOKIPA (HOOK) - Expected net earnings per share growth this year|Earnings per share growth in current year IGM Biosciences, Inc. (IGMS)|ITOS - Earnings per share growth rate in current year|Ocean Bio - Net earnings per share growth this year|Earnings per share increase in current year TCBP|Third Harmonic Bio - Earnings growth in current year
